These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3003815

  • 21. Retinoids are potent inhibitors of the generation of rat leukocyte leukotriene B4-like activity in vitro.
    Bray MA.
    Eur J Pharmacol; 1984 Feb 10; 98(1):61-7. PubMed ID: 6325211
    [Abstract] [Full Text] [Related]

  • 22. Neutrophil aggregation and chemokinesis assays.
    Ford-Hutchinson AW, Evans JF.
    Methods Enzymol; 1988 Feb 10; 162():72-8. PubMed ID: 2852299
    [No Abstract] [Full Text] [Related]

  • 23. Effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes in unstimulated and leukotriene B4-stimulated human skin.
    Wozel G, Chang A, Barth J, Happle R, van de Kerkhof PC.
    Skin Pharmacol; 1990 Feb 10; 3(1):45-8. PubMed ID: 2167697
    [No Abstract] [Full Text] [Related]

  • 24. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.
    Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ.
    Nature; 1980 Jul 17; 286(5770):264-5. PubMed ID: 6250050
    [Abstract] [Full Text] [Related]

  • 25. Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
    Wetterholm A, Macchia L, Haeggström JZ.
    Arch Biochem Biophys; 1994 Jun 17; 311(2):263-71. PubMed ID: 8203889
    [Abstract] [Full Text] [Related]

  • 26. Receptor-specific mechanisms for the responses of human leukocytes to leukotrienes.
    Goetzl EJ, Sherman JW, Ratnoff WD, Harvey JP, Eriksson E, Seaman WE, Baud L, Koo CH.
    Ann N Y Acad Sci; 1988 Jun 17; 524():345-55. PubMed ID: 2837968
    [No Abstract] [Full Text] [Related]

  • 27. Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.
    Thomsen MK, Larsen CG, Thomsen HK, Kirstein D, Skak-Nielsen T, Ahnfelt-Rønne I, Thestrup-Pedersen K.
    J Invest Dermatol; 1991 Feb 17; 96(2):260-6. PubMed ID: 1846901
    [Abstract] [Full Text] [Related]

  • 28. Analogs of leukotriene B4: effects of modification of the hydroxyl groups on leukocyte aggregation and binding to leukocyte leukotriene B4 receptors.
    Leblanc Y, Fitzsimmons BJ, Charleson S, Alexander P, Evans JF, Rokach J.
    Prostaglandins; 1987 May 17; 33(5):617-25. PubMed ID: 3035618
    [Abstract] [Full Text] [Related]

  • 29. Mechanisms of leukotriene B4-specific chemotactic deactivation of human polymorphonuclear leukocytes.
    Boggs JM, Goetzl EJ.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 May 17; 21A():399-402. PubMed ID: 1847775
    [No Abstract] [Full Text] [Related]

  • 30. The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages.
    Doig MV, Ford-Hutchinson AW.
    Prostaglandins; 1980 Dec 17; 20(6):1007-19. PubMed ID: 6259695
    [Abstract] [Full Text] [Related]

  • 31. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.
    Goldman DW, Pickett WC, Goetzl EJ.
    Biochem Biophys Res Commun; 1983 Nov 30; 117(1):282-8. PubMed ID: 6318749
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships.
    Lee TH, Lympany P, Crea AE, Spur BW.
    Biochem Biophys Res Commun; 1991 Nov 14; 180(3):1416-21. PubMed ID: 1659416
    [Abstract] [Full Text] [Related]

  • 33. Comparative biological activities of synthetic leukotriene B4 and its omega-oxidation products.
    Ford-Hutchinson AW, Rackham A, Zamboni R, Rokach J, Roy S.
    Prostaglandins; 1983 Jan 14; 25(1):29-37. PubMed ID: 6302739
    [No Abstract] [Full Text] [Related]

  • 34. Neutrophil aggregating and chemokinetic properties of a 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid isolated from human leukocytes.
    Camp RD, Woollard PM, Mallet AI, Fincham NJ, Ford-Hutchinson AW, Bray MA.
    Prostaglandins; 1982 May 14; 23(5):631-41. PubMed ID: 6289379
    [Abstract] [Full Text] [Related]

  • 35. Metabolism of arachidonic acid by human neutrophils. Characterization of the enzymatic reactions that lead to the synthesis of leukotriene B4.
    Sun FF, McGuire JC.
    Biochim Biophys Acta; 1984 Jun 06; 794(1):56-64. PubMed ID: 6329309
    [Abstract] [Full Text] [Related]

  • 36. Arachidonic acid and leukotriene B4 induce aggregation of human peripheral blood mononuclear leucocytes in vitro.
    Villa S, Colotta F, de Gaetano G, Semeraro N.
    Br J Haematol; 1984 Sep 06; 58(1):137-46. PubMed ID: 6087875
    [Abstract] [Full Text] [Related]

  • 37. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).
    Surette ME, Krump E, Picard S, Borgeat P.
    Mol Pharmacol; 1999 Nov 06; 56(5):1055-62. PubMed ID: 10531413
    [Abstract] [Full Text] [Related]

  • 38. [Pharmacology of the leukotrienes].
    Sirois P, Borgeat P.
    J Pharmacol; 1984 Nov 06; 15 Suppl 1():53-68. PubMed ID: 6328128
    [Abstract] [Full Text] [Related]

  • 39. Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response.
    Kreisle RA, Parker CW, Griffin GL, Senior RM, Stenson WF.
    J Immunol; 1985 May 06; 134(5):3356-63. PubMed ID: 2984287
    [Abstract] [Full Text] [Related]

  • 40. Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn.
    Tan ND, Davidson D.
    Pediatr Res; 1995 Jul 06; 38(1):11-6. PubMed ID: 7478787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.